MannKind Enter into an Agreement with One Drop to Combine Bluetooth-Connected Inhaler with Dose Detection into the One Drop Platform

MannKind Enter into an Agreement with One Drop to Combine Bluetooth-Connected Inhaler with Dose Detection into the One Drop Platform

Shots:

  • MannKind and One Drop collaborate to integrate MannKind’s BluHale, a Bluetooth connected accessory attached to Afrezza inhaler in to the One drop platform. In H1’19, One drop announced clinical study results assessing Afrezza with One Drop, which demonstrated improvement in A1C levels
  • The focus of the agreement is to provide seamless experience for patients using Afrezza with automatic tracking of insulin doses and empowers patients with AI-enabled glucose forecasts, predictive insights, and one-on-one connection with One Drop’s certified diabetes educator
  • Afrezza (insulin human) is an inhaled insulin indicated to improve glycemic control in patients with diabetes mellitus and is administered through a small & portable inhaler involved in reduction in the blood sugar level within a minute of administration

Click here to­ read full press release/ article | Ref: MannKind Corporation | Image: LifeOmic